Regulation of the Tec family of non-receptor tyrosine kinases in cardiovascular disease.
Zeyu YinYuanming ZouDong WangXinyue HuangShengjun XiongLiu CaoYing ZhangYing-Xian SunNaijin ZhangPublished in: Cell death discovery (2022)
Tyrosine phosphorylation by protein tyrosine kinases (PTKs) is a type of post-translational modification. Tec kinases, which are a subfamily of non-receptor PTKs, were originally discovered in the hematopoietic system and include five members: Tec, Btk, Itk/Emt/Tsk, Etk/Bmx, and Txk/Rlk. With the progression of modern research, certain members of the Tec family of kinases have been found to be expressed outside the hematopoietic system and are involved in the development and progression of a variety of diseases. The role of Tec family kinases in cardiovascular disease is receiving increasing attention. Tec kinases are involved in the occurrence and progression of ischemic heart disease, atherosclerosis, cardiac dysfunction associated with sepsis, atrial fibrillation, myocardial hypertrophy, coronary atherosclerotic heart disease, and myocardial infarction and post-myocardial. However, no reviews have comprehensively clarified the role of Tec kinases in the cardiovascular system. Therefore, this review summarizes research on the role of Tec kinases in cardiovascular disease, providing new insights into the prevention and treatment of cardiovascular disease.
Keyphrases
- cardiovascular disease
- left ventricular
- atrial fibrillation
- type diabetes
- heart failure
- cardiovascular risk factors
- randomized controlled trial
- oxidative stress
- acute kidney injury
- coronary artery
- intensive care unit
- systematic review
- tyrosine kinase
- risk assessment
- percutaneous coronary intervention
- mitral valve
- venous thromboembolism
- left atrial appendage
- aortic stenosis
- ejection fraction